Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of GW786034 in Patients With Relapsed or Refractory Soft Tissue Sarcoma

NCT00297258 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00297258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00297258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of GW786034 in Patients With Relapsed or Refractory Soft Tissue Sarcoma
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2005
Completion date
February 28, 2014
Enrollment
148 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma, soft tissue